CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 166 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $335 | -8.5% | 28,682 | +5.3% | 0.00% | 0.0% |
| Q2 2023 | $366 | -27.5% | 27,226 | -10.6% | 0.00% | -33.3% |
| Q1 2023 | $505 | -8.5% | 30,457 | +2.6% | 0.00% | -25.0% |
| Q4 2022 | $552 | -99.9% | 29,678 | -7.2% | 0.00% | +33.3% |
| Q3 2022 | $410,000 | +272.7% | 31,993 | +104.0% | 0.00% | +200.0% |
| Q2 2022 | $110,000 | -34.1% | 15,685 | -22.3% | 0.00% | 0.0% |
| Q1 2022 | $167,000 | +32.5% | 20,193 | +8.3% | 0.00% | 0.0% |
| Q4 2021 | $126,000 | +50.0% | 18,642 | +17.4% | 0.00% | – |
| Q3 2021 | $84,000 | +12.0% | 15,885 | +22.0% | 0.00% | – |
| Q2 2021 | $75,000 | +47.1% | 13,022 | +17.4% | 0.00% | – |
| Q1 2021 | $51,000 | – | 11,094 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
| Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
| Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
| CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
| Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
| Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
| AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
| KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |